CAMBRIDGE, Mass., Oct. 17 /PRNewswire-FirstCall/ -- Biopure Corporation (NASDAQ:BPURDNASDAQ:BPUR) announced today that the board of directors...
Myocardial salvage, erythropoeitic effect and quality of life indications to be pursued CAMBRIDGE, Mass., Oct. 15 /PRNewswire-FirstCall/...
CAMBRIDGE, Mass., Oct 2 /PRNewswire-FirstCall/ -- Biopure Corporation (NASDAQ:BPUR) said today that a one-for-five reverse stock split became...
Biopure's Stock Symbol Reverts to BPUR CAMBRIDGE, Mass., June 27 /PRNewswire-FirstCall/ -- Biopure Corporation (NASDAQ:BPUR) announced today...
Biopure Regains Nasdaq Listing Compliance CAMBRIDGE, Mass., June 15 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPURD; BPUR...
U.S. Navy Seeks FDA Okay to Start Trauma Trial of Hemopure(R) Naval Medical Research Center Submits IND Application for Proposed "RESUS" Clinical...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.